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TECHNICAL NOTES
Diagnosis of vascular prosthesis infection with
FDG-PET/CT
Petr Štádler,a Otakar Bìlohlávek,b Miroslav Špacˇek,a and Pavel Michálek, a Prague, Czech Republic
Fluorodeoxyglucose positron emission tomography (FDG-PET) is on the verge of becoming an established imaging tool
in the fields of clinical oncology, cardiology, and neurology. Because of the high glucose uptake of inflammatory cells,
FDG scanning is an appropriate tool for use in tracing suspected inflammation or to evaluate infection. PET, although
highly sensitive, often lacks the ability to define the precise anatomic location of abnormal FDG accumulation. The new
PET/computed tomography (CT) technology provides precise registration of metabolic and structural imaging data in
a single session. We report positive FDG-PET/CT findings in an infected vascular prosthesis 6 months after grafting. Our
experience and a few available case reports support the hypothesis that FDG-PET/CT may have a promising role in future
noninvasive diagnosis of infected vascular grafts. ( J Vasc Surg 2004;40:1246-7.)Vascular prosthesis infection ranks among the most seri-
ous complications in vascular surgery. Vascular graft infection
is usually diagnosed with computed tomography (CT) or
magnetic resonance imaging. Ultrasound scanning with la-
beled white blood cell scanning and gallium scanning may be
used as ancillarymethods to establish vascular graft infection.1
Positron emission tomography (PET) with 2-deoxy-2-
[18F]fluoro-D-glucose (FDG) has become an important im-
aging tool in clinical oncology, cardiology, and neurology,
and has recently been used in the diagnosis of infectious
diseases with elevated intracellular glucose metabolism.2 Glu-
cose accumulates in malignant and inflammatory cells.3 The
uptakemechanism in infectious and inflammatory diseases has
not yet been fully elucidated, but it appears to be related to the
fact that glucose is the sole energy source of granulocytes and
macrophages during their metabolic burst.4 Therefore PET,
with capability to detect increased glucose levels, represents a
new method for use in diagnosing vascular prosthesis infec-
tion. Although MEDLINE includes hundreds of references
to the key word “infection, vascular prosthesis,” only a few
reports relate to the use of FDG-PET for diagnosis of vascular
prosthesis infection.5-7
PET is an imaging technique that enables identification of
abnormalities by analyzing cellularmetabolic properties rather
than their anatomic density. The fusion of FDG-PET and CT
scans, acquired in a single session, enables precise localization
of any abnormal FDG uptake.8 This hybrid PET/CT
method, while providing precise metabolic and structural
imaging data, may enhance the potential use of FDG in
diagnosis and management of infected vascular grafts.
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1246CASE REPORT
A54-year-oldman had fever accompanying aminor defect in the
right lower limb heel and multiple defects in the left lower limb. The
medical history revealed that a right-sided patent femoropopliteal
polytetrafluoroethylene (Gore-Tex;W.C.Gore andAssociates) distal
bypass had been performed 6 months previously. The operation
wounds were completely healed. Blood cultures were obtained, and
methicillin-resistant Staphylococcus aureus (MRSA) was found. Ultra-
sound examination proved reduced flow in the bypass graft, with no
exudate around the graft. Magnetic resonance angiograms showed
wall thrombi and left-sided superficial femoral artery obliteration.
MRSAwas also cultivated from all defects, and vancomycin treatment
was consequently initiated. Leukocyte count was close to the upper
limit of normal. Because of persistently high temperature, vascular
graft infection was suspected, and FDG-PET/CT examination was
performed. Ninety minutes after intravenous administration of 375
MBq of FDG, data acquisition at CT was started, with intravenous
administration of 95 mL of Omipaque 300. Without moving the
patient, 3-dimensional PET was subsequently performed with the
Biograph duo LSO hybrid PET/CT scanner (Siemens). The field of
investigation extended from the mesogastrium to below the knees in
multiple 3-minute bed positions.
CT scans alone revealed no specific signs of graft infection, except
for a faint, partially developed, nonspecific hypodense rim around
some parts of the graft (Fig 1). However, intense abnormal FDG
uptake along the vascular graftwas recordedwithPET (Fig 2).On the
basis of a clearly positive combined FDG-PET/CT investigation, the
graft was removed and substituted with a vein from the left lower
limb. The graft was found to be infected and incompletely incorpo-
rated into the surrounding tissues. There was a small quantity of
slightly cloudy liquid around the prosthesis. The explanted vascular
graft was sent for culture and genetic examination, which confirmed
the presence of MRSA.
DISCUSSION
Graft infection is a serious complication of vascular sur-
gery, with highmorbidity andmortality. FDG-PET is becom-
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infection areminimal. Combined FDG-PET/CTmay poten-
tially have an incremental benefit over PET alone, because of
its ability to accurately localize the tracer uptake in the infected
anatomic structure.5FDG-PET can rapidly provide anatomi-
cally clear images of defined areas of inflammation with ele-
vated glucose metabolism. Prompt diagnosis is particularly
important for detection of vascular prosthesis infection by a
life-threatening aortoenteric fistula.6 This method may also
prove useful for diagnosis of rare vascular prosthesis infection
caused by Listeria monocytogenes.7 The literature offers a ret-
rospective analysis of 167 FDG-PET investigations of inflam-
mation. All 3 vascular cases, according to the article, showed
accurate PET results.8The possibility of false positive findings
must be kept in mind. Venous thrombosis, sterile inflamma-
tion, vasculitis, chronic polyarthritis, or retroperitoneal fibro-
sis may all lead to an abnormal accumulation of FDG. Fur-
thermore, the early phase of wound healing is physiologically
accompanied by an increased accumulation of FDG. However,
according to our experience, a wound will heal in 6 weeks, after
which the FDG level subsequently decreases. When FDG-PET
findings are positive after this initial healingperiod, the possibility
of vascular prosthesis infection should be considered. FDG is not
specific for infection, and a sterile inflammation, such as macro-
phage infiltration of atherosclerotic plaque, can also cause
an accumulation of FDG. Published case reports emphasize
the problem of vascular prosthesis infection and the poten-
tial opportunity for early diagnosis with FDG-PET. The
FDG-PET/CT combination can precisely specify the ana-
tomic location of pathologic FDG accumulation.9
In conclusion, FDG-PET/CT may enhance the prom-
ising role of FDG in evaluation and management of in-
fected vascular grafts and provide a useful tool for nonin-
vasive diagnosis of this clinical problem. Consequently, an
extensive study should be undertaken to determine the role
of FDG-PET in diagnosis of vascular prosthesis infection
Fig 1. Computed tomography scan of right thigh shows no spe-
cific signs of vascular graft infection except for a partially developed
nonspecific hypodense faint rim around some parts of graft.compared with the standard methods currently applied.REFERENCES
1. Orton DF, Leveen RF, Saigh JA, Culp WC, Fidler JL, Lynch TJ, et al.
Aortic prosthetic graft infections: radiologic manifestations and implica-
tions for management. RadioGraphics 2000;20:977-93.
2. Cook GJ, Fogelman I, Maisey MN. Normal physiological and benign
pathological variants of 18-fluoro-2-deoxyglucose positron-emission to-
mography scanning: potential for error in interpretation. Semin Nucl
Med 1996;26:308-14.
3. De Winter F, Vogelaers D, Gemmel F, Dierckx RA. Promising role of
18-F-fluoro-D-deoxyglucose positron emission tomography in clinical
infectious diseases. Eur J Clin Microbiol Infect Dis 2002;21:247-57.
4. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratu-
moral distribution of tritiated fluorodeoxyglucose in breast carcinoma:
are inflammatory cells important? J Nucl Med 1995;36:1854-61.
5. Keidar Z, Engel A, Nitecki S, Bar Shalom R, Hoffman A, Israel O.
PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose for the evaluation of
suspected infected vascular graft. Mol Imag Biol 2003;5:23-5.
6. Krupnick AS, Lombardi JV, Engels FH, Kreisel D, Zhuang H, Alavi
Carpenter JP. 18-fluorodeoxyglucose positron emission tomography as a
novel imaging tool for the diagnosis of aortoenteric fistula and aortic
graft infection: a case report. Vasc Endovasc Surg 2003;37:363-6.
7. Rohde H, Horstkotte MA, Loeper S, Aberle J, JenickeL, Lampidis R, et al.
Recurrent Listeria monocytogenes aortic graft infection: confirmation of re-
lapse by molecular subtyping. Diagn Microbiol Infect Dis 2004;48:63-7.
8. Chacko TK, Zhuang H, Nakhoda KZ, Moussavian B, Alavi A. Applica-
tions of fluorodeoxyglucose positron emission tomography in the diag-
nosis of infection. Nucl Med Commun 2003;24:615-24.
9. Townsend DW, Carney JP, Yap JT, Hall NC. PET/CT today and
tomorrow. J Nucl Med 2004;45(Suppl 1):S4-14.
Fig 2. Positron emission tomography scan demonstrates intense
abnormal fluorodeoxyglucose uptake from groin to knee. Uptake
is more prominent in central part of thigh. On FDG-PET/CT
fused image, focus is precisely localized to vascular graft.Submitted Jun 2, 2004; accepted Sep 27, 2004.
